Dimensional Fund Advisors LP Purchases 460,108 Shares of Concentrix Corporation $CNXC

Dimensional Fund Advisors LP grew its position in Concentrix Corporation (NASDAQ:CNXC) by 18.5% in the first quarter, HoldingsChannel.com reports. The fund owned 2,951,378 shares of the company’s stock after buying an additional 460,108 shares during the period. Dimensional Fund Advisors LP’s holdings in Concentrix were worth $80,746,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the company. Royal Bank of Canada raised its stake in Concentrix by 9.5% in the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after buying an additional 4,133 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after buying an additional 181,546 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Concentrix by 17.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock worth $8,152,000 after acquiring an additional 21,746 shares during the period. Focus Partners Wealth bought a new position in shares of Concentrix during the 1st quarter worth approximately $781,000. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after acquiring an additional 522 shares during the last quarter. 90.34% of the stock is currently owned by institutional investors and hedge funds.

Concentrix Stock Performance

Shares of Concentrix stock opened at $24.90 on Friday. Concentrix Corporation has a fifty-two week low of $19.12 and a fifty-two week high of $57.88. The company has a debt-to-equity ratio of 1.46, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a market capitalization of $1.52 billion, a P/E ratio of -1.17, a P/E/G ratio of 0.49 and a beta of 0.47. The company’s 50 day moving average price is $25.09 and its two-hundred day moving average price is $29.23.

Concentrix (NASDAQ:CNXC) last posted its earnings results on Monday, June 29th. The company reported $2.63 earnings per share for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The company had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.47 billion. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The business’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, equities analysts forecast that Concentrix Corporation will post 9.67 earnings per share for the current fiscal year.

Concentrix Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 4th. Investors of record on Friday, July 24th will be given a dividend of $0.36 per share. The ex-dividend date is Friday, July 24th. This represents a $1.44 dividend on an annualized basis and a yield of 5.8%. Concentrix’s payout ratio is currently -6.75%.

Analyst Ratings Changes

CNXC has been the topic of a number of research analyst reports. Robert W. Baird dropped their price target on Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 30th. Zacks Research cut shares of Concentrix from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 2nd. Bank of America decreased their price objective on shares of Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a report on Tuesday, June 30th. Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a research report on Friday, July 24th. Finally, Barrington Research reduced their price target on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $32.75.

Concentrix Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.